Early Anticoagulation in Acute Ischemic Stroke With Atrial Fibrillation
Early anticoagulation with non-vitamin K oral anticoagulants reduces recurrent ischemic stroke risk in acute ischemic stroke patients with atrial fibrillation, as confirmed by randomized controlled trials and meta-analyses. Safety concerns remain in high-risk subgroups including severe stroke, hemorrhagic transformation, and Asian populations who are underrepresented in clinical trial data.